Published in Ann Thorac Surg on June 01, 2002
Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments. J Cell Biol (2004) 7.38
Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A (2005) 6.16
Mesenchymal stromal cells: current understanding and clinical status. Stem Cells (2010) 4.79
Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res (2011) 4.75
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med (2006) 3.81
Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation (2005) 3.33
Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation (2003) 2.75
Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng (2010) 2.66
One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci U S A (2003) 2.65
Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther (2002) 2.63
Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol (2005) 2.60
Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res (2004) 2.50
Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage. Ann Thorac Surg (2009) 2.06
Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics (2007) 1.90
Mesenchymal stem cells and tissue engineering. Methods Enzymol (2006) 1.71
Stem cells in the umbilical cord. Stem Cell Rev (2006) 1.63
Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circ Res (2011) 1.62
Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors. Stem Cells (2009) 1.60
Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res (2015) 1.57
Electrophysiological properties of human mesenchymal stem cells. J Physiol (2003) 1.53
Continuing differentiation of human mesenchymal stem cells and induced chondrogenic and osteogenic lineages in electrospun PLGA nanofiber scaffold. Biomaterials (2006) 1.41
The advancing field of cell-based therapy: insights and lessons from clinical trials. J Am Heart Assoc (2013) 1.40
Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential. Bone Marrow Res (2010) 1.34
Adult bone marrow-derived cells: regenerative potential, plasticity, and tissue commitment. Basic Res Cardiol (2005) 1.32
Cell-based therapy for prevention and reversal of myocardial remodeling. Am J Physiol Heart Circ Physiol (2012) 1.31
Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat. Cell Mol Neurobiol (2006) 1.28
Capturing the stem cell paracrine effect using heparin-presenting nanofibres to treat cardiovascular diseases. J Tissue Eng Regen Med (2010) 1.23
Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction. Inflammation (2007) 1.18
Human embryonic stem cells and cardiac repair. Transplant Rev (Orlando) (2008) 1.15
Fabrication of cardiac patch with decellularized porcine myocardial scaffold and bone marrow mononuclear cells. J Biomed Mater Res A (2010) 1.15
Therapeutic potential of mesenchymal stem cells in regenerative medicine. Stem Cells Int (2013) 1.14
In vitro Differentiation Potential of Mesenchymal Stem Cells. Transfus Med Hemother (2008) 1.12
Inflammatory bowel disease: Moving toward a stem cell-based therapy. World J Gastroenterol (2008) 1.10
Human embryonic stem cell-derived CD34+ cells function as MSC progenitor cells. Bone (2010) 1.10
Human adult bone marrow-derived somatic cell therapy results in functional recovery and axonal plasticity following stroke in the rat. Exp Neurol (2008) 1.10
The bone marrow--cardiac axis of myocardial regeneration. Prog Cardiovasc Dis (2007) 1.10
Durable scar size reduction due to allogeneic mesenchymal stem cell therapy regulates whole-chamber remodeling. J Am Heart Assoc (2013) 1.09
Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation. J Cell Mol Med (2012) 1.08
Direct injection of autologous mesenchymal stromal cells improves myocardial function. Biochem Biophys Res Commun (2009) 1.08
Label-free enrichment of functional cardiomyocytes using microfluidic deterministic lateral flow displacement. PLoS One (2012) 1.08
Smooth muscle cell phenotype modulation and contraction on native and cross-linked polyelectrolyte multilayers. Biomacromolecules (2009) 1.07
Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response. Biol Blood Marrow Transplant (2007) 1.07
Adult bone-marrow stem cells and their potential in medicine. J R Soc Med (2004) 1.06
Mesenchymal stem cell transplantation improves regional cardiac remodeling following ovine infarction. Stem Cells Transl Med (2012) 1.06
Mesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challenges. Am J Stem Cells (2013) 1.05
Hypoxia-inducible vascular endothelial growth factor-engineered mesenchymal stem cells prevent myocardial ischemic injury. Mol Ther (2011) 1.05
Assessment of a nuclear affinity labeling method for tracking implanted mesenchymal stem cells. Cell Transplant (2008) 1.05
Hyperbaric oxygenation enhances transplanted cell graft and functional recovery in the infarct heart. J Mol Cell Cardiol (2009) 1.05
Human mesenchymal stem cells - current trends and future prospective. Biosci Rep (2015) 1.04
Cardiovascular gene therapy: current status and therapeutic potential. Br J Pharmacol (2007) 1.03
Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential. Stem Cells Dev (2012) 1.02
Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Relieve Acute Myocardial Ischemic Injury. Stem Cells Int (2015) 1.01
Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells. Expert Opin Biol Ther (2010) 1.00
Culture and Use of Mesenchymal Stromal Cells in Phase I and II Clinical Trials. Stem Cells Int (2010) 0.99
Clinical applications of mesenchymal stem cells in chronic diseases. Stem Cells Int (2014) 0.98
Mesenchymal stromal cells for cardiovascular disease. J Cardiovasc Dis Res (2011) 0.98
Stem cells for heart cell therapies. Tissue Eng Part B Rev (2008) 0.98
Cardiac applications for human pluripotent stem cells. Curr Pharm Des (2009) 0.97
Myocardial remodeling: cellular and extracellular events and targets. Annu Rev Physiol (2011) 0.97
Scarred myocardium imposes additional burden on remote viable myocardium despite a reduction in the extent of area with late contrast MR enhancement. Eur Radiol (2005) 0.96
Stem cell differentiation and expansion for clinical applications of tissue engineering. J Cell Mol Med (2007) 0.96
Cancer stem cells as targets for cancer therapy: selected cancers as examples. Arch Immunol Ther Exp (Warsz) (2008) 0.95
GATA-4 promotes myocardial transdifferentiation of mesenchymal stromal cells via up-regulating IGFBP-4. Cytotherapy (2011) 0.95
Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms. Stem Cell Res Ther (2014) 0.95
Cellular self-organization by autocatalytic alignment feedback. J Cell Sci (2011) 0.94
Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice. J Korean Med Sci (2006) 0.94
Mesenchymal stem cell: present challenges and prospective cellular cardiomyoplasty approaches for myocardial regeneration. Antioxid Redox Signal (2009) 0.94
Preparatory studies of composite mesenchymal stem cell islets for application in intraportal islet transplantation. Ups J Med Sci (2010) 0.93
Bone marrow-derived mesenchymal stem cells in fibrin augment angiogenesis in the chronically infarcted myocardium. Regen Med (2009) 0.93
Immunomodulation by mesenchymal stem cells in veterinary species. Comp Med (2013) 0.93
Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury. Neurol Res Int (2011) 0.92
Evidence of mobilization of pluripotent stem cells into peripheral blood of patients with myocardial ischemia. Exp Hematol (2010) 0.92
Mesenchymal stem cells for cardiac regeneration: translation to bedside reality. Stem Cells Int (2012) 0.92
Laser-patterned stem-cell bridges in a cardiac muscle model for on-chip electrical conductivity analyses. Lab Chip (2011) 0.92
Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells. Cardiovasc Diabetol (2010) 0.91
Paracrine effect of Wnt11-overexpressing mesenchymal stem cells on ischemic injury. Stem Cells Dev (2011) 0.90
Stem cell therapy for cardiac dysfunction. Springerplus (2014) 0.90
Gravity, a regulation factor in the differentiation of rat bone marrow mesenchymal stem cells. J Biomed Sci (2009) 0.90
Microfluidic artificial "vessels" for dynamic mechanical stimulation of mesenchymal stem cells. Integr Biol (Camb) (2012) 0.90
Transplantation of mesenchymal stem cells within a poly(lactide-co-epsilon-caprolactone) scaffold improves cardiac function in a rat myocardial infarction model. Eur J Heart Fail (2009) 0.89
The antiapoptotic effect of mesenchymal stem cell transplantation on ischemic myocardium is enhanced by anoxic preconditioning. Can J Cardiol (2009) 0.88
A nondenatured, noncrosslinked collagen matrix to deliver stem cells to the heart. Regen Med (2011) 0.88
Human salivary gland stem cells ameliorate hyposalivation of radiation-damaged rat salivary glands. Exp Mol Med (2013) 0.87
Directed Fusion of Mesenchymal Stem Cells with Cardiomyocytes via VSV-G Facilitates Stem Cell Programming. Stem Cells Int (2012) 0.87
Stem celltherapy for ischemic heart failure. Tex Heart Inst J (2005) 0.87
Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease. Stem Cells Transl Med (2015) 0.87
Hematopoietic stem cells: ex-vivo expansion and therapeutic potential for myocardial ischemia. Stem Cells Cloning (2010) 0.87
Fate and effects of adult bone marrow cells in lungs of normoxic and hyperoxic newborn mice. Am J Respir Cell Mol Biol (2008) 0.86
Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora's Box. Stem Cells Int (2011) 0.86
Platelet rich plasma clot releasate preconditioning induced PI3K/AKT/NFκB signaling enhances survival and regenerative function of rat bone marrow mesenchymal stem cells in hostile microenvironments. Stem Cells Dev (2013) 0.86
Cardiac regeneration using pluripotent stem cells--progression to large animal models. Stem Cell Res (2014) 0.86
The use of gadolinium-carbon nanostructures to magnetically enhance stem cell retention for cellular cardiomyoplasty. Biomaterials (2013) 0.84
Pre-transplantation specification of stem cells to cardiac lineage for regeneration of cardiac tissue. Stem Cell Rev (2009) 0.83
Rapid and dynamic alterations of gene expression profiles of adult porcine bone marrow-derived stem cell in response to hypoxia. Stem Cell Res (2010) 0.83
Cell therapy with bone marrow cells for myocardial regeneration. Antioxid Redox Signal (2009) 0.83
Tracking fusion of human mesenchymal stem cells after transplantation to the heart. Stem Cells Transl Med (2015) 0.83
A comparison of the efficacy of transplantation of bone marrow-derived mesenchymal stem cells and unrestricted somatic stem cells on outcome after acute myocardial infarction. Stem Cell Res Ther (2012) 0.83
Mesenchymal stem cells for treatment of myocardial infarction. Int J Stem Cells (2008) 0.83
Effect of 5-azacytidine on the protein expression of porcine bone marrow mesenchymal stem cells in vitro. Genomics Proteomics Bioinformatics (2006) 0.82
Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood (2004) 13.79
A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet (2005) 9.62
Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation (2002) 7.97
Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res (2004) 6.34
Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A (2005) 6.16
Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell (2011) 6.11
Overview of BioCreative II gene mention recognition. Genome Biol (2008) 5.67
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature (2010) 5.26
Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation (2005) 4.03
In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation (2003) 4.00
Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation (2005) 3.83
Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat Med (2007) 3.61
Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation (2005) 3.33
Stroke and encephalopathy after cardiac surgery: an update. Stroke (2005) 2.91
OpenDMAP: an open source, ontology-driven concept analysis engine, with applications to capturing knowledge regarding protein transport, protein interactions and cell-type-specific gene expression. BMC Bioinformatics (2008) 2.81
Introducing meta-services for biomedical information extraction. Genome Biol (2008) 2.78
Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation (2003) 2.75
Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed (2004) 2.54
MutationFinder: a high-performance system for extracting point mutation mentions from text. Bioinformatics (2007) 2.53
U-Compare: share and compare text mining tools with UIMA. Bioinformatics (2009) 2.28
Clinical outcomes of noninfectious sternal dehiscence after median sternotomy. Ann Thorac Surg (2006) 2.25
Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke (2008) 2.18
Association of pulmonary conduit type and size with durability in infants and young children. Ann Thorac Surg (2013) 2.06
Watershed strokes after cardiac surgery: diagnosis, etiology, and outcome. Stroke (2006) 1.98
Concept annotation in the CRAFT corpus. BMC Bioinformatics (2012) 1.94
Coronary artery bypass grafting with or without surgical ventricular restoration: a comparison. Ann Thorac Surg (2008) 1.92
Evaluation of lexical methods for detecting relationships between concepts from multiple ontologies. Pac Symp Biocomput (2006) 1.90
BioLemmatizer: a lemmatization tool for morphological processing of biomedical text. J Biomed Semantics (2012) 1.90
Interstage mortality after the Norwood procedure: Results of the multicenter Single Ventricle Reconstruction trial. J Thorac Cardiovasc Surg (2012) 1.79
Mitochondrial resuscitation with exogenous cytochrome c in the septic heart. Crit Care Med (2007) 1.76
Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J (2008) 1.76
Increased mortality at low-volume orthotopic heart transplantation centers: should current standards change? Ann Thorac Surg (2008) 1.68
A 32-year experience with surgical repair of sinus of valsalva aneurysms. J Card Surg (2005) 1.68
Impact of the lung allocation score on resource utilization after lung transplantation in the United States. J Heart Lung Transplant (2010) 1.67
Valproic acid prevents brain injury in a canine model of hypothermic circulatory arrest: a promising new approach to neuroprotection during cardiac surgery. Ann Thorac Surg (2006) 1.64
Outcomes after the stage I reconstruction comparing the right ventricular to pulmonary artery conduit with the modified Blalock Taussig shunt. Ann Thorac Surg (2005) 1.63
Delirium after coronary artery bypass graft surgery and late mortality. Ann Neurol (2010) 1.63
Application of haptic feedback to robotic surgery. J Laparoendosc Adv Surg Tech A (2004) 1.62
Extracorporeal membrane oxygenation after stage I reconstruction for hypoplastic left heart syndrome. Pediatr Crit Care Med (2006) 1.60
Cognitive and neurologic outcomes after coronary-artery bypass surgery. N Engl J Med (2012) 1.58
Simple score to assess the risk of rejection after orthotopic heart transplantation. Circulation (2012) 1.57
Do management strategies for coronary artery disease influence 6-year cognitive outcomes? Ann Thorac Surg (2009) 1.56
Predictive value of intraoperative diagnosis of residual ventricular septal defects by transesophageal echocardiography. Ann Thorac Surg (2010) 1.50
Biomedical discovery acceleration, with applications to craniofacial development. PLoS Comput Biol (2009) 1.49
A corpus of full-text journal articles is a robust evaluation tool for revealing differences in performance of biomedical natural language processing tools. BMC Bioinformatics (2012) 1.46
Aortic valve replacement and concomitant coronary artery bypass: assessing the impact of multiple grafts. Ann Thorac Surg (2007) 1.46
Intraoperative hemoglobin levels and transfusion independently predict stroke after cardiac operations. Ann Thorac Surg (2011) 1.45
Pilot implementation of a perioperative protocol to guide operating room-to-intensive care unit patient handoffs. J Cardiothorac Vasc Anesth (2011) 1.45
Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. Basic Res Cardiol (2008) 1.44
Subjective memory symptoms in surgical and nonsurgical coronary artery patients: 6-year follow-up. Ann Thorac Surg (2009) 1.43
Cognition 6 years after surgical or medical therapy for coronary artery disease. Ann Neurol (2008) 1.41
Dose-related effects of repeated ETC-216 (recombinant apolipoprotein A-I Milano/1-palmitoyl-2-oleoyl phosphatidylcholine complexes) administrations on rabbit lipid-rich soft plaques: in vivo assessment by intravascular ultrasound and magnetic resonance imaging. J Am Coll Cardiol (2008) 1.41
Pharmacological preconditioning ameliorates neurological injury in a model of spinal cord ischemia. Ann Thorac Surg (2002) 1.41
Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann Thorac Surg (2007) 1.39
The anesthetic management and physiologic implications in infants with anomalous left coronary artery arising from the pulmonary artery. J Cardiothorac Vasc Anesth (2011) 1.39
Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties. Int J Cardiol (2005) 1.37
Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides. Blood (2004) 1.35
Corpus refactoring: a feasibility study. J Biomed Discov Collab (2007) 1.29
Cognitive changes with coronary artery disease: a prospective study of coronary artery bypass graft patients and nonsurgical controls. Ann Thorac Surg (2003) 1.29
Molecular markers of cardiac endocardial cushion development. Dev Dyn (2003) 1.22
EuroSCORE predicts short- and mid-term mortality in combined aortic valve replacement and coronary artery bypass patients. J Card Surg (2010) 1.22
Encephalopathy and stroke after coronary artery bypass grafting: incidence, consequences, and prediction. Arch Neurol (2002) 1.20
Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology (2005) 1.20
The impact of center volume on survival in lung transplantation: an analysis of more than 10,000 cases. Ann Thorac Surg (2009) 1.20
Controversies, genetics, diagnostic assessment, and outcomes relating to the heterotaxy syndrome. Cardiol Young (2007) 1.18
Neurocognitive outcomes 3 years after coronary artery bypass graft surgery: a controlled study. Ann Thorac Surg (2007) 1.18
Association of operative time of day with outcomes after thoracic organ transplant. JAMA (2011) 1.16
Determining the utility of temporary pacing wires after coronary artery bypass surgery. Ann Thorac Surg (2005) 1.15
Common variation in ISL1 confers genetic susceptibility for human congenital heart disease. PLoS One (2010) 1.15
Inspiring medical students to pursue surgical careers: outcomes from our cardiothoracic surgery research program. Ann Thorac Surg (2009) 1.14
Gata4 and Gata5 cooperatively regulate cardiac myocyte proliferation in mice. J Biol Chem (2009) 1.12
The impact of donor-recipient sex matching on survival after orthotopic heart transplantation: analysis of 18 000 transplants in the modern era. Circ Heart Fail (2009) 1.08
Impact of donor-to-recipient weight ratio on survival after heart transplantation: analysis of the United Network for Organ Sharing Database. Circulation (2008) 1.08
Mesenchymal stem cell transplantation improves regional cardiac remodeling following ovine infarction. Stem Cells Transl Med (2012) 1.06
Contemporary etiologies, risk factors, and outcomes after pericardiectomy. Ann Thorac Surg (2012) 1.05
Aortic valve replacement and concomitant mitral valve regurgitation in the elderly: impact on survival and functional outcome. Circulation (2005) 1.04
Pulmonary capillaries are recruited during pulsatile flow. J Appl Physiol (1985) (2002) 1.03
Organ storage with University of Wisconsin solution is associated with improved outcomes after orthotopic heart transplantation. J Heart Lung Transplant (2011) 1.03
Mandatory versus selective preoperative carotid screening: a retrospective analysis. Ann Thorac Surg (2004) 1.03
Operative outcomes in mitral valve surgery: combined effect of surgeon and hospital volume in a population-based analysis. J Thorac Cardiovasc Surg (2012) 1.02
Improving protein function prediction methods with integrated literature data. BMC Bioinformatics (2008) 1.02
Development of a quantitative donor risk index to predict short-term mortality in orthotopic heart transplantation. J Heart Lung Transplant (2011) 1.02
Rapid pattern development for concept recognition systems: application to point mutations. J Bioinform Comput Biol (2007) 1.01
Mitochondrial ATP-sensitive potassium channel activation protects cerebellar granule neurons from apoptosis induced by oxidative stress. Stroke (2003) 0.98
Two thousand Blalock-Taussig shunts: a six-decade experience. Ann Thorac Surg (2007) 0.98
Incidence of and risk factors for perioperative optic neuropathy after cardiac surgery. Ann Thorac Surg (2004) 0.98
Exploring species-based strategies for gene normalization. IEEE/ACM Trans Comput Biol Bioinform (2010) 0.97
Factors influencing neurologic outcome after neonatal cardiopulmonary bypass: what we can and cannot control. Ann Thorac Surg (2006) 0.96
Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest. ACS Nano (2014) 0.96
MRL mice fail to heal the heart in response to ischemia-reperfusion injury. Wound Repair Regen (2005) 0.96
Semaphorin 3d signaling defects are associated with anomalous pulmonary venous connections. Nat Med (2013) 0.94
Contemporary outcomes of surgical ventricular septal defect closure. J Thorac Cardiovasc Surg (2013) 0.94
Early postoperative cognitive dysfunction and blood pressure during coronary artery bypass graft operation. Arch Neurol (2007) 0.94
A UIMA wrapper for the NCBO annotator. Bioinformatics (2010) 0.93
Critical heart disease in the neonate: presentation and outcome at a tertiary care center. Pediatr Crit Care Med (2008) 0.93
The impact of race on survival after heart transplantation: an analysis of more than 20,000 patients. Ann Thorac Surg (2010) 0.92
Intravenous glutamine enhances COX-2 activity giving cardioprotection. J Surg Res (2008) 0.92
Mutations in Hedgehog pathway genes in fetal rhabdomyomas. J Pathol (2013) 0.92
Feridex-labeled mesenchymal stem cells: cellular differentiation and MR assessment in a canine myocardial infarction model. Acad Radiol (2005) 0.92